ArticleOncotarget2016

Hypermethylated in cancer 1(HIC1) suppresses non-small cell lung cancer progression by targeting interleukin-6/Stat3 pathway.

Xiumin Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.